Treatment of high‐risk relapsed Wilms tumor with dose‐intensive chemotherapy, marrow‐ablative chemotherapy, and autologous hematopoietic stem cell support: Experience by the Italian association of pediatric hematology and oncology
暂无分享,去创建一个
A. Jenkner | A. Pession | L. Piva | F. Fagioli | P. Collini | R. Luksch | D. Perotti | F. Spreafico | L. Gandola | P. D’Angelo | S. Dallorso | G. Bisogno | G. Casazza